ArticleCureus2026
Diagnostic Accuracy of Sputum and Bronchoscopy-Guided Cytology Compared With Bronchial Biopsy in Pulmonary Lesions.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchial biopsy remains the reference standard for diagnosing pulmonary pathology; however, minimally invasive cytological techniques are increasingly used in clinical practice. This study aimed to determine the diagnostic accuracy of sputum cytology, bronchoalveolar lavage (BAL) cytology, transbronchial needle aspiration (TBNA), and bronchial brush cytology in detecting malignant pulmonary lesions using bronchial biopsy as the reference standard, and to compare their relative diagnostic performance.
methodsA prospective observational study was conducted at Government Medical College, Datia, from March to September 2025. A total of 120 adult patients with clinical and radiological suspicion of pulmonary pathology underwent sputum cytology and bronchoscopy-guided sampling (BAL, TBNA, brush cytology), followed by bronchial biopsy. Histopathology served as the reference standard. Diagnostic performance parameters were calculated. Suspicious cytology results were considered positive for malignancy for sensitivity analysis.
resultsOf 120 patients, 77 (64.2%) had malignant lesions on biopsy. TBNA cytology demonstrated the highest sensitivity (92.2%) and excellent diagnostic accuracy (area under the curve (AUC) 0.969), followed by brush cytology (sensitivity 85.7%, AUC 0.974). BAL cytology showed moderate sensitivity (71.4%, AUC 0.887), while sputum cytology had lower sensitivity (49.4%, AUC 0.808). All modalities showed statistically significant associations with histopathology (p < 0.001). TBNA and brush cytology exhibited superior concordance with biopsy findings compared with BAL and sputum cytology.
conclusionBronchoscopy-guided cytological techniques, particularly TBNA and brush cytology, demonstrate high diagnostic accuracy and strong concordance with bronchial biopsy findings. These modalities serve as valuable complementary diagnostic tools in selected clinical settings but do not replace histopathological confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.